| Sl.No | RC / IEC Number | Name of the Principal Investigator / Department | Name of the Co Investigators / Department | Title | Funding Agency | Amount Sanctioned | Status of the project |
|---|---|---|---|---|---|---|---|
| 1 | PIMS/Ethics/2009-10 | Dr. Anil J Purty / Community Medicine | Dr. Preetam Mahajan, Dr (Brig) Zile Singh, Dr. Natesan Murugan, Dr. Johnson Cherian, Dr. Joy Bazroy & Mr. Senthilvel – Community Medicine, Ms. A Meenakshi - Biochemistry |
Prevalence of goitre and urinary iodine status of school children in Puducherry - progress towards elimination of Iodine Deficiency Disorders (IDD) | State Health Department, Puducherry | Rs. 1,59,000 | Completed |
| 2 | PIMS/Ethics/2009-10 | Dr.Anil J Purty / Community Medicine | Dr (Brig) Zile Singh, Dr. Joy Bazroy, Dr. Johnson Cherian, Dr. Murugan M & Mr. Senthilvel - Community Medicine Dr. K H Kisku - Respiratory Medicine |
Tuberculosis case-finding and treatment under RNTCP: patient, health system delays in and around Puducherry | RNTCP State Task Force Operational Research fund, Puducherry | Rs. 4,97,300 | Completed |
| 3 | PIMS/Ethics/2009-10 | Dr. Anil J Purty / Community Medicine | Dr. Padma &
Dr. Lal Bahadur Palo - OBG, Dr. Vivekanandan – General Medicine, Dr. Shashikala & Dr. Patricia Anita - Microbiology, Dr. Renu G’Boy Varghese - Pathology, Dr. K H Kisku & Dr. Pratima Singh – Respiratory Medicine, Dr. Nateshan Bhumika, Dr. Murugan Natesan, Dr (Brig) Zile Singh& Dr. Y Sharma – Community Medicine, Mr. Senthilvel - Biostatistics |
Health care seeking behavior among Extra-pulmonary TB(EPTB) including Female Genital Tuberculosis (FGTB) patients under RNTCP in and around Puducherry | ICMR | Rs.31,35,598 | Completed |
| 4 | PIMS/IEC/Research Proposal/2011-01 | Dr. Anil J Purty / Community Medicine | Dr. P Stalin, Dr. Ramesh Chauhan, Dr (Brig) Zile Singh, Dr. Yogesh Sharma – Community Medicine Dr. Mark Christopher – Cardiology Ms. Maghida – Dietetics Dr. Prasanna Sundara Raju – Physical Education Dr. Sangeetha Narayanasamy – Pondicherry University |
Effectiveness of diet and lifestyle intervention through Information Education Communication (IEC) tools with Angan Wadi Centres (AWCs) as the centre of knowledge dissemination for hypertension (including hypercholesterolemia and diabetes) risk reduction – a cluster randomised controlled trial | ICMR | Rs. 1.7 Crores | Completed |
| 5 | RC/2014/25 | Dr.Anil J Purty / Community Medicine | Dr. Amit Kumar Mishra, Dr. Ramesh Chauhan, Dr. Prahan Kumar, Dr. P Stalin & Dr. Joy Bazroy – Community Medicine |
Developing an innovative tribal health system model estimate burden of TB co-infections and improve the effectiveness of RNTCP in India- ICMR. Multicentericstudy | ICMR | Rs. 54,58,374 | Completed |
| 6 | PIMS/IEC/Research Proposal/2014-2015 | Dr.Sheela Devi / Micrbiology 2014-2015 | Dr.Georgi Abraham – General Medicine Dr.Reba Kanungo, Dr.Vivian Joseph Ratnam, Dr.Ramya SR, Dr.Anusha Rohit- Microbiology Dr.Ezhilnilavan Sampath & Dr.Sreejith- Nephrology |
Rapid detection and identification of bacterial pathogens in cases of peritonitis following continuous ambulatory peritoneal dialysis | TamilnadKidney Research (TANKER)Foundation | Rs.2,00,000/- | Completed |
| 7 | RC/16/118 | Dr. P Stalin / Community Medicine | Dr. Manikandan, Dr.Vincent Antony, Dr.Murugan & Dr.(Brig) Zile Singh - Community Medicine |
Identifying and addressing factors contributing to pre-treatment loss to follow up of tuberculosis patients referred for treatment from medical colleges in Pondicherry: A Quasi Experimental study | Global Fund (The Global Fund to Fight AIDS, Tuberculosis and Malaria)Implementation Research | Rs.19,26,068/- | Completed |
| 8 | RC/16/156 | Dr.Anil J Purty / Community Medicine | Dr. Ashok Kumar Das - General Medicine, Dr.Murugan & Dr.Rajesh Kumar Konduru - Community Medicine |
INDIAB Study (Puducherry) | ICMR | Rs.42,00,000/- | Completed |
| 9 | RC/17/31 | Dr.Sathya GR / Physiology | Dr.Priscilla Johnson, Dr.Subhasis Das - Physiology |
Evaluating the role of periostin as a novel biomarker in Asthmatics of Puducherry | Science and Engineering Research Board | Rs.3,16,150/- | Completed |
| 10 | RC/17/32 | Dr.D.Rekha / Physiology | Dr.Priscilla Johnson, Dr.Subhasis Das - Physiology |
Role of soluble Urokinase-Type Plasminogen Activator. Receptor (SUPAR) as a predictor of Chronic Obstructive Pulmonary Disease Severity | Science and Engineering Research Board | Rs.5,95,000/- | Completed |
| 11 | RC/17/34 | Dr. Ramya S R / Microbiology | Dr.Shashikala Nair & Dr.Reba Kanungo - Microbiology, Dr.Veeraraghavan K - Gastroenterology, Dr.Georgi Abraham - General Medicine |
Occult hepatitis B virus infection among hemodialysis and chronic liver disease patients in a tertiary care hospital. | Tamilnadu Kidney Research (TANKER)Foundation | Rs. 1,25,000 | Completed |
| 12 | RC/18/52 | Dr.Anil J Purty / Community Medicine | Dr. S. Mahendran, Dr.Amit Kumar Misra & Dr. S. Kalaiselvi - Community Medicine Dr.Aneesh Basheer - General Medicine Dr.Nishanth S - Paediatrics Dr. Kevin Manuel - Pathology Dr. Reba Kanungo & Dr.Shashikala -Microbiology Dr. Sunil Nanda - Biochemistry |
A Phase I/II, Double Blind, Placebo controlled, Randomized, Multicenter, prospective study to evaluate the Safety and Immunogenicity of a single dose ‘Dengue Tetravalent Vaccine, Live Attenuated (Recombinant, Lyophilized)’ in healthy subjects: Panacea Biotech (Sponsor) for a Phase III study of Dengue Vaccine development | Panacea Biotech | Rs, 20,62,370/- | Completed |
| 13 | RC/18/59 | Dr.Sandhya Bhat K / Microbiology | Dr. Shashikala - Microbiology & Dr. Vasanthi - General Medicine |
Serotype and genotype analysis of dengue virus by RT-PCR and sequencing from in and around Puducherry ICMR | ICMR | Rs. 13,35,000/- | Completed |
| 14 | RC/18/105 | Dr.Anil J Purty / Community Medicine | Dr.Swasti Tiwari (SGPGI, Lucknow), Dr.Newtonraj & Dr.Stalin P - Community Medicine, Dr.Sivaa R - Biochemistry, Dr.Moses Ambroise - Pathology |
CARE - Kidney Disease - Biomarkers and newer Therapeutics. | ICMR | Rs. 5.0 Crores | Completed |
| 15 | RC/19/52 | Dr.Arish/ Anaesthesiology | Dr.Hariharasudhan, Dr.Ranjan R V, Dr.Mamie Zachariah & Dr.Sagiev G. Koshy - Anaesthesiology |
Comparison of anaesthetic efficacy of ropivacaine and ropivacaine with nalbuphine as an adjuvant for ultrasound guided supraclavicular brachial plexus blockade: A randomized controlled trial. | NEON pharmaceuticals with a research intent | Rs.44,950/- | Completed |
| 16 | RC/20/88 | Dr.Anil J Purty / Community Medicine | Dr.Sudhagar M & Dr.NayyarIqbal - General Medicine, Dr. King Herald Kisku & Dr. Prince George Varughese - Respiratory Medicine, Dr.JohnyAsir, Dr.Vivian Joseph Ratnam P - Microbiology, Dr. Isabella Topno & Dr.Aravinda Kumar B - Pharmacology, Dr.Stalin. P, Dr. Rajesh Kumar Konduru, Dr.Murugan N, Dr. R Prahan Kumar, Dr.Velavan A, Dr.Newtonraj A, Dr.Manikandan M, Dr.Abhilasha Nair - Community Medicine, Dr. J. Ramesh & Dr. L. Ravivarman - Govt of Puducherry |
Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multicentre Phase III Adaptive Clinical Trial to Assess the Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for SARS-Cov-2 Infection in Indian Healthy Subjects | Human Vaccine LLC, Russia & Dr. Reddy’s Laboratories Limited, India | Rs. 36 Lakhs | Completed |
| 17 | RC/2020/87 | Dr.Anil J Purty / Community Medicine | Dr. Joy Bazroy, Dr. Stalin P, Dr. Rajesh Kumar Konduru, Dr. Murugan N, Dr. R Prahan Kumar, Dr. Amit Kumar Mishra, Dr.Velavan, Dr.Newtonraj A, Dr. Manikandan M, Dr.Abilasha Nair & Dr.Tovia Stephen - Community Medicine Dr.Reba Kanungo & Dr.Shashikala - Microbiology Dr.Aneesh Basheer - General Medicine Dr Sunil Kumar Nanda - Biochemistry Dr Kevin Manuel E - Pathology Dr Nishanth Rajan - Paediatrics |
Community based surveillance for Dengue / DSS at the Urban and Rural Health Training Centres and Govt. Primary Health Centres in the field practice areas of Pondicherry Institute of Medical Sciences, Puducherry. | National Biopharma Mission,Department of Biotechnology BIRAC | Rs.5.7 Crores | Completed |
| 18 | RC/2021/17 | Dr. Remya Raj/ Dermatology, PIMS (Co-PI) | Dr. Vijesh Sreedhar Kuttiatt – VCRC (PI) Dr. Philip Raj Abraham - VCRC, Dr. Kiran CM - Pathology |
Verrucous and hyperkeratotic lesions in filarial lymphedema affected limbs: Clinico-pathological characteristics and association with HPV infection. | Vector Control Research Centre-ICMR | Rs. 1,00,000 | Completed |
| 19 | RC/2021/19 | Dr. Anil J Purty/ Community Medicine | Dr. Rajesh Kumar Konduru, Dr. A. Velavan & Dr. Manikandan - Community Medicine |
Epidemiological impact and intersection of the COVID-19 and tuberculosis pandemics in Brazil, Russia, India and South Africa (MPAC19TB) | Department of Biotechnology | Rs. 11,60,352 | Completed |
| 20 | RC/2021/57 | Dr. Nayyar Iqbal/ General Medicine | Dr. Vasanthi, Dr. Ali H F Karnam, Dr. Poornima Raj & Dr. Priscilla Rubavathy – General Medicine Dr. Velavan – Community Medicine Dr. Ravichandran - Biostatistics Dr. Mithun Raj - Radiology |
Optimizing duration of anticoagulation following acute venous thromboembolism (VTE) by assessing residual venous thrombosis by ultrasound – a multicenter randomized controlled trial | ICMR | Rs. 33,75lakhs | Completed |
| 21 | RC/2022/26 | Dr. Anita/Pathology | Dr. Anand Mohanraj - Pathology Dr. David – General Surgery Dr. Poornima – General Medicine |
Hospital Based Cancer Registry-Data Management Software-PIMS, in collaboration with ICMR-NCDIR | ICMR / National Centre for Disease Informatics and Research | Non Funded. Only Technical Support. | Completed |
| 22 | RC/2022/36 | Dr. Pradeep Thilakan / Psychiatry | Dr. Parthasarathy, Mr. Saravanan & Dr. Rohit Balakrishnan - Psychiatry |
A PHASE II/III, prospective, multi-center, randomized, 4-week, double-blind, placebo-controlled study, designed to determine the safety, tolerability, EEG effects and efficacy of oral doses of 30 mg bid of Evenamide (nw-3509) in patients with chronic schizophrenia who are symptomatic on their current second-generation antipsychotic (Aripiprazole, Clozapine, Quetiapine, Olanzapine, Paliperidone or Risperidone) medication | NewronPharmaceuticals.p.A., | Rs. 21,00,000/- | Completed |
| 23 | RC/2022/49 | Dr. Trishana Vaishali / DVL | Dr. B. Aravinda Kumar - Pharmacology Dr. Nithiyaa P - DVL |
A Randomized, Double Blind, Three-Arm, Placebo Controlled, Parallel Design, multi-center, Clinical Endpoint Bioequivalence study of Ketoconazole Shampoo 2% (Test Product) compared with Ketoconazole Shampoo 2% (Reference Product) in adult subjects with tinea versicolor. | Novitium Pharma (a subsidiary of ANI Pharmaceuticals INC.), 70 Lake Drive, East Windsor,NJ 08520, USA | Rs. 99,500/- | Completed |
| 24 | RC/2022/171 | Dr. Anil J Purty / Community Medicine | Dr. Rajesh Kumar Konduru Dr. Saranya R Dr. Nayyar Iqbal Dr. Nirmal Raj Francis Dr. Shashikala Dr. Sandhya Bhat Dr. Sunil Kumar Nanda Dr. Isabella Topno Dr. Manjunatha C H Dr. Kevin Manuel Dr. P Stalin Dr. Velavan A Dr. Manikandan Dr. Sahanaa C Dr. Roselin M |
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Immunogenicity and Safety of Single dose of Dengue Tetravalent Vaccine, Live Attenuated (Recombinant, Lyophilized) – “DengiAll” of Panacea Biotec Limited in Healthy Indian Adults | Rs. 86,68,420/- | Panacea Biotec Limited in Healthy | Ongoing |
| 25 | RC/2023/01 | Dr. Anil Jacob Purty / Community Medicine | Dr. Velavan, Dr. Rajesh Kumar Konduru, Dr. Stalin P, Dr. Murugan N, Dr. Joy Bazroy, Dr. Manikandan, Dr. Saranya R & Dr. M Roselin – Community Medicine Dr. Shashikala & Dr. Vivian Joesph Ratnam - Microbiology Dr. Nayyar Iqbal – General Medicine Dr. Sunil Kumar Nanda - Biochemistry Dr. Nishanth Rajan - Paediatrics Dr. Kevin Manuel - Pathology |
Community based surveillance to estimate incidence and sero prevalence of acute febrile illness with focus on Dengue and Chikungunya – A prospective multi-centric cohort study | National Biopharma Mission, Department of Biotechnology BIRAC | Rs. 3,08,41,000 | Completed |
| 26 | RC/2023/53 | Dr. Sandhya Bhat / Microbiology (Site PI) | Dr. Kalyani Borde (PI) Dr. Dilip Mathai – General Medicine Dr. Shashikala Nair & Dr. Anusha R - Microbiology |
Impact of rapid antibiotic susceptibility testing (RAST) on clinical outcomes of patients with sepsis in low-resource settings | International Society Infectious Disease / European Society for Clinical Microbiology and Infectious Diseases Fellowship Grant | USD 7500 | Ongoing |
| 27 | RC/2023/70 | Dr. Ali Hasan Faiz Karnam /Emergency Medicine | Dr. Roselin M & Dr. Saranya R – Community Medicine Dr. Naveen Kumar - ICU Dr. Charulatha Tamilselvan – Emergency Medicine |
Factors associated with sudden deaths among adults aged 18-45 years, India : Multicentric matched case-control study | ICMR / National Institute of Epidemiology | Rs. 1,50,000 | Completed |
| 28 | RC/2023/75 | Dr. Peter Prasanth Kumar Kommu/ Paediatrics (Site PI) | Dr. Michelle Joseph, PhD (PI) Dr. Nishanth Rajan Dr. Priya Jose |
Bayley Scales of Infant and Toddler Development (4th Edition) : Pearson Copyright and Pearson India Standardisation Project | Rs. 4,56,600 | Pearson India Education Services. Pvt. Ltd | Completed |
| 29 | RC/2023/79 | Dr. Sunil Subramaniam / Forensic Medicine (Site PI) | Dr. Kiruthiga U – PhD Scholar. NFSU (PI) Dr. Rajesh - Forensic Medicine, IGMC |
Establishing Identity of the Dead Bodies through Fingerprints using Scientific and Macrophotography Techniques | Rs. 1.8 lakhs | International Committee of Red Cross | Ongoing |
| 30 | RC/2023/83 | Dr. Rajesh Kumar Konduru / Community Medicine | Dr. B. Aravinda Kumar Dr. Saranya R Dr. Isabella Topno Dr. Anil J Purty Dr. Nayyar Iqbal Dr. Manjunatha Dr. Anusha – JIPMER Dr. Dineshbabu – JIPMER Dr. Sudharsanan - JIPMER |
Implementation of inter-departmental collaborative medication review to reduce potentially inappropriate medication use in the hospitalized elderly patients: A mixed method study | Rs. 93,65,926 | ICMR | Ongoing |
| 31 | RC/2024/08 | Dr. P Stalin / Community Medicine (Site PI) | Prof Jane Hirst, University Of Oxford – PI, Dr Devarsetty Praveen - George Institute for Global Health (India) Dr Pallavi Kshetrapal - Translational Health Science and Technology Institute Prof Shinjini Bhatnagar - Translational Health Science and Technology Institute Dr Vidhya Venugopal - Sri Ramachandra Institute of Higher Education and Research Prof Sagnik Dey - Indian Institute of Technology Delhi Prof BaskyThilaganathan - St George's, University of London Dr Aris Papageorghiou - University of Oxford Prof Manu Vatish- University of Oxford Prof Fadil Hannan - University of Oxford Prof Mark Woodward - Imperial College London |
Effects of extreme heat on maternal, placental and fetal physiology, lactation and newborn health in India | £1,994,787.00 | Wellcome Trust, UK | Ongoing |
| 32 | - | Dr. Manikandan / Community Medicine | Dr. Ramachandran Thiruvengadam, Dr. Shinjini Bhatnagar Dr. Arindam Maitra |
MOMI India - Genomics and analysis planning | BIRAC | INR: 10,65,90,798.60 (Total budget) Rs.35,80,605.60 for PIMS Rs.12,25,113 utilized | Ongoing |
| 33 | - | Dr. Velavan, Community Medicine | - | Availability, Affordability of Essential Medicines and Acceptability of Generic Drugs in Five Districts of Tamil Nadu and Puducherry: A Mixed Method Study” | ICSSR | Rs. 1500000 Only Data Collection | Completed |
| 34 | RC/2024/104 | Dr. Sheela Devi C / Microbiology | Dr. Meghna C Dr. Mary Daniel Dr. G Seghal Kiran Prof Joseph Selvin – Pondicherry University Dr. R Latha - AVMCRI |
Dissecting the role of vaginal and urinary tract Microbiome Dysbiosis in recurrent Urinary Tract Infections: A case control study | ICMR | Rs. 17500/- | Ongoing |
| 35 | RC/2024/105 | Dr. Mary Daniel/ OBG | Dr. Roselin M | A multicentric evaluation of Indian population-specific tools for antenatal estimation of gestational age | BIRAC- Grand Challenges India Programme, Govt. of India | Rs.75,04,200 | Ongoing |
| 36 | RC/2024/106 | Dr. Pradeep Thilakan / Psychiatry | Dr. Parthasarathy Dr. Rohit Balakrishnan |
A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s) | NewronPharmaceuticals.p.A., | Rs. 4,99,296/- for One patient. Total of 30 patient | Ongoing |
| 37 | RC/2025/19 | Dr. Jacob Jayakar/ General Surgery | Dr. Mary Daniel Dr. Sheela Devi Dr. Ariganesan |
A multimodal, adaptive, intervention to prevent perioperative infection and reduce morbidity and mortality: a stepped-wedge cluster RCT (The Modified Clean Cut | ICMR | Rs.7,82,800/- | Ongoing |
| 38 | RC/2025/164 | Dr Anil J Purty / Community Medicine | Dr. Velavan A Dr. Stalin P Dr. Nivya Jeet Daniel Dr. Johnson O Dr. Lal Bahadur Palo Dr. Manikandan M |
International Network for Vaccine Safety Surveillance (INNOVATE): An integrated population and sentinel hospital-based vaccine safety surveillance in six low and middle-income countries. | Coalition for Epidemic Preparedness Innovations | Rs. 2,60,31,566 | Ongoing |